Related references
Note: Only part of the references are listed.In vitro time-kill kinetics of dalbavancin against Staphylococcus spp. biofilms over prolonged exposure times
Vincenzo Di Pilato et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2020)
Biofilm-active antibiotic treatment improves the outcome of knee periprosthetic joint infection: Results from a 6-year prospective cohort study
Max Gellert et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Effect of Dalbavancin on Staphylococcal Biofilms When Administered Alone or in Combination With Biofilm-Detaching Compounds
Migle Ziemyte et al.
FRONTIERS IN MICROBIOLOGY (2020)
Antibiotic penetration into bone and joints: An updated review
Abrar K. Thabit et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2019)
Real-world experience with dalbavancin therapy in gram-positive skin and soft tissue infection, bone and joint infection
Selma Tobudic et al.
INFECTION (2019)
Timing of implant-removal in late acute periprosthetic joint infection: A multicenter observational study
Marjan Wouthuyzen-Bakker et al.
JOURNAL OF INFECTION (2019)
No lower bacterial adhesion for ceramics compared to other biomaterials: An in vitro analysis
P. A. Slullitel et al.
ORTHOPAEDICS & TRAUMATOLOGY-SURGERY & RESEARCH (2018)
Dalbavancin for treatment of implant-related methicillin-resistant Staphylococcus aureus osteomyelitis in an experimental rat model
Manuel Kussmann et al.
SCIENTIFIC REPORTS (2018)
Emergence of a dalbavancin induced glycopeptide/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis
Manuel Kussmann et al.
EMERGING MICROBES & INFECTIONS (2018)
Vancomycin displays time-dependent eradication of mature Staphylococcus aureus biofilms
Virginia Post et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2017)
Extended-Duration Dosing and Distribution of Dalbavancin into Bone and Articular Tissue
Michael W. Dunne et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection
Helen W. Boucher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Organism Profile in Periprosthetic Joint Infection: Pathogens Differ at Two Arthroplasty Infection Referral Centers in Europe and in the United States
Vinay K. Aggarwal et al.
JOURNAL OF KNEE SURGERY (2014)
Reduced Vancomycin Susceptibility in an In Vitro Catheter-Related Biofilm Model Correlates with Poor Therapeutic Outcomes in Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus
Wessam Abdelhady et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Activity of dalbavancin, alone and in combination with rifampicin, against meticillin-resistant Staphylococcus aureus in a foreign-body infection model
Daniela Baldoni et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children
Catherine Liu et al.
CLINICAL INFECTIOUS DISEASES (2011)
Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus
Warren E. Rose et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Adis drug profile - Dalbavancin
Vanessa R. Anderson et al.
DRUGS (2008)
Dalbavancin compared with vancomycin for prevention of Staphylococcus aureus colonization of devices in vivo
RO Darouiche et al.
JOURNAL OF INFECTION (2005)
Structural mechanism for rifampicin inhibition of bacterial RNA polymerase
EA Campbell et al.
CELL (2001)
Share Paper
